Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Pharmacielo Ltd V.PCLO

Alternate Symbol(s):  PCLOF

PharmaCielo Ltd. is a Canada-based global company with a focus on ethical and sustainable cultivating, processing and supply of all natural, pharmaceutical-grade medical dried cannabis flower and cannabis products to large channel distributors. The Company has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo Colombia cultivates and processes the Company’s all-natural cannabis into standardized, medicinal-grade dried cannabis flower, cannabis oil extracts and cannabis related products sold in bulk to pharmaceutical companies and medicinal cannabis distributors globally. In Colombia, PharmaCielo Colombia is a fully licensed cultivator, producer, and distributor of both tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis extracts. Ubiquo is a knowledge management and medical consultation system that aims to create access to healthcare for Colombians.


TSXV:PCLO - Post by User

Post by bronkrdron Dec 26, 2020 2:32pm
334 Views
Post# 32183983

10 tonnes of dry flower $$$$$ for 2021

10 tonnes of dry flower $$$$$ for 2021Notes from Henning von Koss

Following the Colombian government granting a high-THC quota to PharmaCielo in July of 2020, the Company commenced its first commercial cultivation of psychoactive proprietary cultivars in 5.5 hectares of its open-air greenhouses in Rionegro. I am pleased to share with you that we are now completing the first cycle harvest of this new crop that is expected to yield more than 10 tonnes of dry flower for extract processing, destined for export. These high-THC extracts are an important addition to PharmaCielo’s expanded product portfolio, as we discussed in our most recent Investors Update.
<< Previous
Bullboard Posts
Next >>